Mel Spigelman
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
-
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 6
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Mycobacterium research and diagnosis 3
- Pneumonia and Respiratory Infections 2
- Co-authors
- Khisimuzi Mdluli (1 shared paper)Richard O’Brien (1 shared paper)Mario Raviǵlione (1 shared paper)Michael Höelscher (1 shared paper)J. Gheuens (1 shared paper)Alimuddin Zumla (1 shared paper)Christian Lienhardt (1 shared paper)Richard Hafner (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)Clinics in Chest Medicine (1 paper)The Medical Journal of Australia (1 paper)Current Opinion in Pharmacology (1 paper)
- Partner nations
- United StatesSwitzerlandSouth Africa
In The Last Decade
Mel Spigelman
10 papers receiving 361 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 272
- Epidemiology 171
- Molecular Medicine 24
- Toxicology 12
- Molecular Biology 142
Countries citing papers authored by Mel Spigelman
This map shows the geographic impact of Mel Spigelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Spigelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Spigelman more than expected).
Fields of papers citing papers by Mel Spigelman
This network shows the impact of papers produced by Mel Spigelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Spigelman. The network helps show where Mel Spigelman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mel Spigelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 135 | |
| 2 | 2006 | 109 | |
| 3 | 2005 | 57 | |
| 4 | 2009 | 48 | |
| 5 | 2020 | 9 | |
| 6 | 2013 | 9 | |
| 7 | 2022 | 4 | |
| 8 | 1969 | 2 | |
| 9 | 2019 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2023 | 0 |
About Mel Spigelman
Mel Spigelman is a scholar working on Infectious Diseases, Epidemiology, Pediatrics, Perinatology and Child Health, Oncology and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 376 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Mycobacterium research and diagnosis (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pneumonia and Respiratory Infections (2 papers), Pharmaceutical studies and practices (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Infectious Diseases (272 citations), Epidemiology (171 citations), Molecular Medicine (24 citations), Toxicology (12 citations) and Molecular Biology (142 citations). Mel Spigelman has collaborated with scholars based in United States, Switzerland and South Africa. Frequent co-authors include Khisimuzi Mdluli, Richard O’Brien, Mario Raviǵlione, Michael Höelscher, J. Gheuens, Alimuddin Zumla, Christian Lienhardt, Richard Hafner, Ernesto Jaramillo and Ann M. Ginsberg. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Clinics in Chest Medicine, The Medical Journal of Australia and Current Opinion in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.